PHILADELPHIA, Jan. 30, 2015 /PRNewswire/ Spark Therapeutics announced today the pricing of its initial public offering of 7,000,000 shares of common stock at a public offering price of $23.00 per share, before underwriting discounts. What are the highest paying jobs at. These data were presented at the 58th American Society of Hematology Annual Meeting in San Diego, CA, on December 4, 2016. It is a subsidiary of Hoffmann-La Roche History. This 2-year postdoctoral PharmD fellowship program provides an opportunity to gain hands-on experience contributing to the various . Dr. Levy will be responsible for strategic and operational . Spark Therapeutics, a commercial gene therapy company striving to challenge the inevitability of genetic disease, is honored to operate an online learning and educational website called aSharedVision ( www.aSharedVision.com ). The eye-popping $4.8 billion sticker price on Spark Therapeutics' acquisition deal with Roche announced on Monday is shaping up to be the largest exit ever within city limits for a venture-backed company, according to data from financial data provider PitchBook and the Philadelphia Alliance for Capital and Technologies (PACT). We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari. Spark Therapeutics peak revenue was $93.5M in 2021. For more information, visit www.sparktx.com, and follow us on Twitter and LinkedIn . We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our shared mission is to challenge the inevitability of genetic disease by discovering, developing, and delivering treatments in ways unimaginable - until now. Its products include LUXTURNA (voretigene neparvovec) for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy and viable retinal cells. While ZipRecruiter is seeing annual salaries as high as $215,500 and as low as $28,500, the majority of Spark Therapeutics salaries currently range between $99,000 (25th percentile) to $168,500 (75th percentile) with top earners (90th percentile) making $197,500 annually across the United . Today, as a member of the Roche Group, Spark is focused on breaking barriers for . (WORD or PDF document formats only), PI must be qualified by training and experience to undertake the proposed research, If patients are involved, the clinicians practice license must be current and not be excluded, debarred, suspended, or otherwise ineligible to participate in health care programs in their country, PI must not be an employee of Spark or its affiliated entities, The research idea and protocol must be the Principal Investigators or Academic Groups own, unique idea and protocol, The specific scientific project may not have commenced prior to the approval for funding, The PI cannot be the current recipient of a Spark Competitive Research Grant, Multiple applications from the same academic entity are allowed provided that each application protocol is unique, Applicants will grant the right of first refusal to license any inventions arising from the research to Spark or its affiliates, Approval to conduct the study by the local review board (Institutional Review Board, Institutional Ethics Committee, Institutional Animal Review Committee, etc.) This 2-year postdoctoral PharmD fellowship program provides an opportunity to gain hands-on experience contributing to the various functional areas . We dont follow footsteps. The company was founded in 2013 by Katherine A. We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company's product candidates are in the field of retina-directed gene therapies, liver-directed gene therapies, and central nervous system therapies. Founded in 2013, Spark Therapeutics is the first company in the U.S. to receive FDA approval of a gene therapy for a genetic disease. Spark Therapeutics, Inc. is a developer of gene therapy treatments, which treat debilitating genetic diseases. All of the shares in the offering are being sold by Spark. Spark is no longer accepting submissions currently as the deadline for submissions was May 31, 2022. var str = elements[i].innerHTML; Spark also has product candidates in development for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases. Spark Therapeutics will consider funding requests for the disease states we investigate. As a former fellow, I know how a fellowship program can shape your future career in the pharmaceutical industry. Our shared mission is to challenge the inevitability of genetic disease by discovering, developing, and delivering treatments in ways unimaginable until now. Spark Therapeutics is a startup pharmaceutical company that develops gene therapies. To learn more, please see our development pipeline. This unique opportunity will prepare the candidates for a position within Medical Affairs, such as an in-house role within Medical Information, Medical Communications, and field-based Medical Science Liaison (MSL) roles. Spark Therapeutics is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies. You also have the option to opt-out of these cookies. We don't follow footsteps. Spark Therapeutics, Inc. employs 247 employees. Share sensitive information only on official, secure websites. Share. Variations in spelling or abbreviation can produce multiple totals for the same category. Necessary cookies are absolutely essential for the website to function properly. The national average salary for a Spark Therapeutics employee in the United States is $94,398 per year. 1-866-MISPARK / 1-866-647-7275. Link. According to a new press release, the acquisition is being made at a price of "$114.50 per share in an all-cash transaction," corresponding to a "total equity value of approximately $4.8 billion." as appropriate to the study, Ensure safety reporting to Spark and IRB/IEC/Health Authorities (HA), etc. Understand the role and skills required for one of the selected functional areas in the biotechnology industry. UI Health is UIC's academic health enterprise May 27 2022 Spark Therapeutics - Multidisciplinary Medical Affairs Fellowship May 27, 2022 12:00 AM - 12:00 AM Address Philadelphia, PA Calendar Download iCal File We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. At Spark, a member of the Roche Group, we see the path to a world where no life is limited by genetic disease. 24- and 48-Hour Reports of independent expenditures aren't included. Spark is a late clinical-stage gene therapy company seeking to develop one-time, life-altering treatments for debilitating genetic diseases, with an initial focus on treating rare diseases. Spark Therapeutics' relocation gives more space to the laboratory functions with approximately 22,700-square-feet of lab space, 14,800-square-feet of office/meeting/amenity space, and an additional11,200-square-feet of building support and core on the second floor and 9,000-square-feet on the garden level. You may also report side effects to Spark Therapeutics at 1-855-SPARKTX 1-855-SPARKTX (1-855-772-7589) (1-855-772-7589). The Sequoia Spark Fellowship aims to inspire more women in India and Southeast Asia to build companies by increasing their access to capital, mentorship, knowledge and network. Get Contact Info for All Departments Spark Therapeutics, Inc. Org Chart Jeffrey Marrazzo Board of Managers 8 6 (33) var str = elements2[i].innerHTML; Employees in the top 10 percent can make over $161,000 per year, while employees at the bottom 10 percent earn less than $55,000 per year. as appropriate to the study, Submission of study reports and academic abstracts, posters, publication. for (var i = 0; i < elements.length; i++) { Spark Therapeutics may provide grants for financial assistance for scholarships or other educational funds to permit medical students, residents, fellows and other healthcare professionals in training to attend major educational, scientific or policy-making conferences or meetings. * acf_load_time_zone_global_list in index-routing.php Spark Therapeutics 4.4 Medical Affairs Fellow Philadelphia, PA $60K - $98K ( Glassdoor est.) | At Spark Therapeutics, we don't follow footsteps. var elements2 = document.getElementsByClassName('event-time'); // individual event pages It is focused on debilitating genetic diseases by developing one-time, life-altering treatments. Find elections. Peak Revenue $93.5M (2021) Number of Employees 368 At Spark Therapeutics, a fully integrated, commercial company committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases. Allocated operating expenditures - federal, Allocated operating expenditures - non-federal, Allocated federal election activity - federal share, Allocated federal election activity - Levin share. Spark Therapeutics, Inc. | 64,688 followers on LinkedIn. Founded in 2013, Spark Therapeutics is the first company in the U.S . We also use third-party cookies that help us analyze and understand how you use this website. The applicant (Principal Investigator, PI) must have a medical degree (MD or equivalent), advanced scientific degree (PhD or equivalent), advanced nursing degree (MS/PhD), or an advanced degree in an allied healthcare discipline such as pharmacy, respiratory therapy, physical therapy, occupational therapy, or social work where the applicant is affiliated with an eligible organization, Eligible organizations are academic medical centers, research institutes and research foundations, Ineligible applicants include for-profit organizations and individuals not affiliated with an academic or research institution/foundation. access the list of itemized transactions. It was founded in 2013 by Katherine High and Jeffrey Marrazzo in and effort to commercially develop treatments against haemophilia that High was working on at Children's Hospital of Philadelphia. Grants and support are subject to review and approval. Their latest funding was raised on May 27, 2014 from a Series B round. Spark Therapeutics Inc is a United States based company operating in the field of gene therapy. If you have questions about LUXTURNA after reading this information, ask your healthcare professional. This website uses cookies to improve your experience while you navigate through the website. Fellows serve as integral members of the team, contributing to the various functional areas within Medical Affairs. PHILADELPHIA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, today announced the appointment of Gallia Levy, M.D., Ph.D., as chief medical officer. var elements = document.getElementsByClassName('_time'); // component & listing pages Spark Therapeutics's stock symbol is ONCE What is Spark Therapeutics's official website? The ACMG Foundation's Next Generation Fellowship and Training Scholarship Program has worked to address the shortage of medical genetics experts needed to diagnose and treat patients with genetic disorders. TG Therapeutics is currently recruiting for the following positions for the upcoming 2022-2024 cycle: Details about TG, our fellowships, and the application process can be found in the attached brochure. This information does not take the place of talking to your healthcare professional about your medical condition or treatment. Learn how to enable Javascript in your browser. Search by state or ZIP code, Look up contributions from specific individuals, Find and contact your committee's analyst. Roche to Acquire Spark Therapeutics Feb 25, 2019 Roche has entered into a definitive merger agreement to fully acquire Spark Therapeutics.